| Date | Time | Source | Announcement |
|---|---|---|---|
| 09 Mar 2001 | 07:00 AM | Purchase of Own Securities | |
| 07 Mar 2001 | 07:00 AM | Purchase of Own Securities | |
| 01 Mar 2001 | 07:01 AM | Purchase of Own Securities | |
| 27 Feb 2001 | 07:01 AM | Purchase of Own Securities | |
| 26 Feb 2001 | 04:00 PM | Holding in Company | |
| 22 Feb 2001 | 07:00 AM | Purchase of Own Securities | |
| 21 Feb 2001 | 07:01 AM | Regulatory Approval | |
| 20 Feb 2001 | 06:23 PM | Dividend | |
| 20 Feb 2001 | 09:00 AM | Patent Court Ruling Upheld | |
| 12 Feb 2001 | 07:00 AM | Purchase of Own Securities | |
| 09 Feb 2001 | 07:00 AM | Purchase of Own Securities | |
| 08 Feb 2001 | 07:07 AM | Dividend | |
| 08 Feb 2001 | 07:01 AM | Final Results Part 2 of 2 | |
| 08 Feb 2001 | 07:01 AM | Final Results Part 1 of 2 | |
| 07 Feb 2001 | 04:00 PM | Holding in Company | |
| 07 Feb 2001 | 09:00 AM | Notice of Results | |
| 06 Feb 2001 | 05:00 PM | Director Shareholding | |
| 01 Feb 2001 | 12:52 PM | Re Agreement | |
| 19 Jan 2001 | 01:30 PM | Disposal | |
| 09 Jan 2001 | 09:13 AM | Stmnt re Genpharm Inc | |
| 04 Jan 2001 | 10:00 AM | Stmnt re MRP Approval | |
| 22 Dec 2000 | 10:30 AM | Director Shareholding | |
| 19 Dec 2000 | 02:00 PM | Court Ruling | |
| 12 Dec 2000 | 09:45 AM | Result of Meeting - Part 2 | |
| 12 Dec 2000 | 09:45 AM | Result of Meeting - Part 1 | |
| 11 Dec 2000 | 09:15 AM | Notice of Meeting | |
| 17 Nov 2000 | 04:38 PM | Director Shareholding | |
| 17 Nov 2000 | 04:38 PM | Director Shareholding | |
| 17 Nov 2000 | 01:15 PM | Court Ruling | |
| 15 Nov 2000 | 04:00 PM | Director Shareholding | |
| 13 Nov 2000 | 11:02 AM | Re Directorate | |
| 13 Nov 2000 | 08:10 AM | Stmnt re Syngenta AG | |
| 13 Nov 2000 | 07:00 AM | Fthr reSyngentaGlobal Sec Off | |
| 02 Nov 2000 | 10:00 AM | Stmnt re FTC Approval | |
| 02 Nov 2000 | 07:30 AM | Syngenta Suppl. Prospectus | |
| 30 Oct 2000 | 12:00 PM | Stmnt re Divestment | |
| 30 Oct 2000 | 07:30 AM | Syngenta Global Secondary Off | |
| 26 Oct 2000 | 02:00 PM | Re Alliance | |
| 25 Oct 2000 | 07:00 AM | 3rd Qrt & 9 Mths Results-Pt.2 | |
| 25 Oct 2000 | 07:00 AM | 3rd Qrt & 9 Mths Results-Pt.1 | |
| 17 Oct 2000 | 12:12 PM | Corporate Action | |
| 11 Oct 2000 | 12:28 PM | Result of EGM | |
| 09 Oct 2000 | 09:16 AM | Patent Dispute | |
| 21 Sep 2000 | 04:00 PM | Director Shareholding | |
| 18 Sep 2000 | 07:13 AM | Notice of EGM, etc. | |
| 08 Sep 2000 | 03:17 PM | Mylan Lab./Mylan Pharms. | |
| 04 Sep 2000 | 09:30 AM | Regulatory Approval | |
| 29 Aug 2000 | 10:01 AM | Statement re Asthma Treatment | |
| 25 Aug 2000 | 02:16 PM | Directors' Notification of Dealing in Shares | |
| 01 Aug 2000 | 08:09 AM | Dividend Notification |
AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England.
It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It was involved in developing the Oxford–AstraZeneca COVID-19 vaccine.
Astra Zeneca share price launched at 605p in 1993.